A First‐in‐man Safety and Pharmacokinetics Study of Nangibotide, a New Modulator of Innate Immune Response Through TREM‐1 Receptor Inhibition
BJCP British journal of clinical pharmacology/British journal of clinical pharmacology（2018）
关键词
drug safety,pharmacokinetics,Phase I,randomized controlled trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要